AJJ Medtech Holdings Limited (SGX:584)

Singapore · Delayed Price · Currency is SGD

0.0050

0.00 (0.00%)

At close: Jul 24, 2026

AJJ Medtech Holdings Financials Overview

Financials in millions SGD. Fiscal year is January - December.

Millions SGD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2.71	3.19	2.32	1.62	0.6	0.32
Revenue Growth	6.06%	37.41%	43.84%	170.97%	86.83%	-53.29%
Gross Profit	0.82	1.18	0.59	0.7	0.31	0.27
Operating Income	-3.2	-2.87	-3.89	-2.51	-3.88	-3.92
Net Income	-3.26	-2.93	-3.87	-2.53	-4.24	-1.7
Earnings Per Share	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Corporate and Healthcare Wellness Education	0.12	0.31	0.05	0.2	0	-
Healthcare Products and Services	2.56	2.84	2.27	1.37	0.59	0.04
Healthcare Digital Products	0.03	0.04	0	0.04	-	-
Total	2.71	3.19	2.32	1.62	0.6	0.32

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	0.11	0.47	0.25	0.67	0.66	4.36
Total Debt	3.65	3.82	3.11	2.87	1.31	1.54
Net Cash (Debt)	-3.54	-3.35	-2.86	-2.2	-0.66	2.82
Net Cash Growth	-	-	-	-	-	483.64%
Net Cash Per Share	-0.00	-0.00	-0.00	-0.00	-0.00	0.00

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-1.25	-1.14	-1.62	-1.74	-3.2	-5.54
Capital Expenditures	-0.01	-0.01	-0.01	-0	-0.04	-0.5
Free Cash Flow	-1.26	-1.15	-1.62	-1.74	-3.24	-6.04
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	30.31%	36.81%	25.27%	43.28%	52.35%	84.95%
Operating Margin	-117.99%	-90.04%	-167.63%	-155.29%	-651.17%	-1228.53%
Pretax Margin	-120.06%	-91.73%	-166.55%	-158.70%	-668.46%	-544.51%
Profit Margin	-120.21%	-91.82%	-166.38%	-156.47%	-711.58%	-531.66%
FCF Margin	-46.46%	-36.00%	-69.91%	-107.93%	-543.29%	-1894.67%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	3.16	5.36	1.94	4.05	12.53	38.06